Cargando…

Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review

Objective To determine the trade-off between the sensitivity and the specificity for high grade cervical intraepithelial neoplasia at hybrid capture 2 cut-off values above the standard ≥1 relative light units/cut-off level (rlu/co). Design Systematic review. Data sources PubMed. Study selection Rand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rebolj, Matejka, Bonde, Jesper, Njor, Sisse Helle, Lynge, Elsebeth
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099543/ https://www.ncbi.nlm.nih.gov/pubmed/21606136 http://dx.doi.org/10.1136/bmj.d2757

Ejemplares similares

Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study
por: Preisler, Sarah, et al.
Publicado: (2016)

Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above
por: Rebolj, Matejka, et al.
Publicado: (2016)

Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening
por: Rebolj, Matejka, et al.
Publicado: (2014)

Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays
por: Rebolj, Matejka, et al.
Publicado: (2016)

Concurrent participation in breast, cervical, and colorectal cancer screening programmes in Denmark: A nationwide registry-based study
por: Njor, Sisse Helle, et al.
Publicado: (2023)

HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 Human Papillomavirus genotype microarray system
por: Bonde, Jesper, et al.
Publicado: (2014)

Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay
por: Preisler, Sarah, et al.
Publicado: (2013)

Human papillomavirus self‐sampling for screening nonattenders: Opt‐in pilot implementation with electronic communication platforms
por: Lam, Janni Uyen Hoa, et al.
Publicado: (2017)

Adherence to follow‐up after the exit cervical cancer screening test at age 60–64: A nationwide register‐based study
por: Jørgensen, Susanne F., et al.
Publicado: (2021)

Human Papillomavirus Testing in the Last Cervical Screening Round at Age 60–64 Years
por: Schroll, Jeppe Bennekou, et al.
Publicado: (2021)

Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark
por: Rebolj, Matejka, et al.
Publicado: (2015)

Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study
por: Ejegod, Ditte Møller, et al.
Publicado: (2015)

Benefit‐to‐harm ratio of the Danish breast cancer screening programme
por: Beau, Anna‐Belle, et al.
Publicado: (2017)

A simple way to measure the burden of interval cancers in breast cancer screening
por: Andersen, Sune Bangsbøll, et al.
Publicado: (2014)

Overdiagnosis in screening mammography in Denmark: population based cohort study
por: Njor, Sisse Helle, et al.
Publicado: (2013)

Is a delay in the introduction of human papillomavirus-based cervical screening affordable?
por: Castañon, Alejandra, et al.
Publicado: (2018)

Mammographic density in birth cohorts of Danish women: a longitudinal study
por: Hellmann, Sophie Sell, et al.
Publicado: (2013)

Incomplete follow-up of positive HPV tests: overview of randomised controlled trials on primary cervical screening
por: Rebolj, M, et al.
Publicado: (2010)

The optimal cut‐off value in fit‐based colorectal cancer screening: An observational study
por: Njor, Sisse Helle, et al.
Publicado: (2021)

Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening Programme
por: Enerly, Espen, et al.
Publicado: (2016)

Cytology interpretation after a change to HPV testing in primary cervical screening: Observational study from the English pilot
por: Rebolj, Matejka, et al.
Publicado: (2022)

Body mass index and participation in organized mammographic screening: a prospective cohort study
por: Hellmann, Sophie Sell, et al.
Publicado: (2015)

Incidence of cervical cancer after several negative smear results by age 50: prospective observational study
por: Rebolj, Matejka, et al.
Publicado: (2009)

The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
por: Ejegod, Ditte, et al.
Publicado: (2016)

Primary cervical screening with high risk human papillomavirus testing: observational study
por: Rebolj, Matejka, et al.
Publicado: (2019)

HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study
por: Andersen, Berit, et al.
Publicado: (2020)

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders
por: Lam, J U H, et al.
Publicado: (2018)

The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot
por: Rebolj, Matejka, et al.
Publicado: (2022)

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
por: Dillner, Joakim, et al.
Publicado: (2008)

Breast cancer mortality and overdiagnosis after implementation of population-based screening in Denmark
por: Lynge, Elsebeth, et al.
Publicado: (2020)

Screening participation after a false positive result in organized cervical cancer screening: a nationwide register-based cohort study
por: Larsen, Pernille Thordal, et al.
Publicado: (2020)

Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders
por: Lam, J. U. H., et al.
Publicado: (2017)

Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data
por: Rebolj, Matejka, et al.
Publicado: (2022)

Colorectal cancer screening participation among citizens not recommended to be screened: a cohort study
por: Larsen, Pernille Thordal, et al.
Publicado: (2022)

COVID-19 disruption to cervical cancer screening in England
por: Castanon, Alejandra, et al.
Publicado: (2022)

Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test
por: Rijkaart, D C, et al.
Publicado: (2010)

Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses
por: Castanon, Alejandra, et al.
Publicado: (2021)

Breast cancer survivors' risk of interval cancers and false positive results in organized mammography screening
por: Njor, Sisse Helle, et al.
Publicado: (2020)

16/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot
por: Rebolj, Matejka, et al.
Publicado: (2019)

Comparing the Cervista HPV HR Test and Hybrid Capture 2 Assay in a Dutch Screening Population: Improved Specificity of the Cervista HPV HR Test by Changing the Cut-Off
por: Boers, Aniek, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_86oem3q9emqi8kl8p2r0u34lbk